Pan-ebola virus neutralizing human antibodies and methods of use therefor Grant US-11939370-B2 United States of America 26 Mar 2024
Use of pyronaridine, tilorone, and quinacrine against Marburg virus and other virus… Grant US-11696914-B1 United States of America 11 Jul 2023
Human antibodies to Ebola virus glycoprotein Grant US-11530255-B2 United States of America 20 Dec 2022
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant US-11407817-B2 United States of America 09 Aug 2022
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant US-11407816-B2 United States of America 09 Aug 2022
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant US-11254732-B2 United States of America 22 Feb 2022
COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CORONAVIRUS INFECTIONS Application WO-2022034588-A1 World Intellectual Property Organisation (WIPO) 17 Feb 2022
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant US-11242378-B2 United States of America 08 Feb 2022
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant US-11242379-B2 United States of America 08 Feb 2022
Antibodies that bind Ebola glycoprotein and uses thereof Grant US-10894818-B2 United States of America 19 Jan 2021
Monoclonal antibodies and cocktails for treatment of ebola infections Grant US-10836810-B2 United States of America 17 Nov 2020
Human antibodies to Ebola virus glycoprotein Grant US-10829544-B2 United States of America 10 Nov 2020
Monoclonal antibody neutralizing infectivity of all ebola viruses Grant US-10640550-B2 United States of America 05 May 2020
Human antibodies to Ebola virus glycoprotein Grant US-10501526-B2 United States of America 10 Dec 2019
PHYTOMEDICAMENT WITH ANTIVIRAL, ANTIBACTERIAL, ANTIFUNGAL AND ANTIHEMORRAGIC ACTIVITY… Application FR-3080280-A1 France 25 Oct 2019
MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS Application EP-3291837-A4 European Patent Office 07 Aug 2019
MONOCLONAL ANTIBODIES FOR EBOLA AND MARBURG VIRUSES Application EP-3048115-B1 European Patent Office 01 May 2019
EBOLA VIRUS DISEASE VACCINE TAKING HUMAN REPLICATION DEFICIENT ADENOVIRUS AS VECTOR Application EP-3342865-A4 European Patent Office 31 Oct 2018
Human antibodies to Ebola virus glycoprotein Grant US-10081670-B2 United States of America 25 Sep 2018
Human antibodies to ebola virus glycoprotein Grant US-9771414-B2 United States of America 26 Sep 2017
EBOLA VIRUS DISEASE VACCINE TAKING HUMAN REPLICATION DEFICIENT ADENOVIRUS AS VECTOR Application WO-2017128783-A1 World Intellectual Property Organisation (WIPO) 03 Aug 2017
MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS Application US-20160324965-A1 United States of America 10 Nov 2016
MONOCLONAL ANTIBODY COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS Application US-20160326234-A1 United States of America 10 Nov 2016
ANTIBODY-MEDIATED NEUTRALIZATION OF MARBURG VIRUS Application WO-2016138312-A2 World Intellectual Property Organisation (WIPO) 01 Sep 2016
TREATING VIRAL HEMORRHAGIC FEVER WITH NK-92 CELLS Application WO-2016057345-A1 World Intellectual Property Organisation (WIPO) 14 Apr 2016
ANTIBODIES SPECIFIC FOR ENTEROVIRUSES THAT INFECT HUMANS Application WO-2015092668-A1 World Intellectual Property Organisation (WIPO) 25 Jun 2015